Assembly Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-34.9M | $-35.0M | $147.0K | $5.0M |
| FY2017 | $1.9M | $995.0K | $865.0K | $8.6M |
| FY2018 | $-65.0M | $-65.3M | $340.0K | $28.5M |
| FY2019 | $-84.1M | $-85.6M | $1.6M | $20.6M |
| FY2020 | $-63.0M | $-63.4M | $470.0K | $21.9M |
| FY2021 | $-93.4M | $-96.5M | $3.1M | $5.2M |
| FY2022 | $-84.5M | $-84.6M | $102.0K | $6.6M |
| FY2023 | $22.7M | $22.5M | $255.0K | $5.1M |
| FY2024 | $-51.1M | $-51.1M | $28.0K | $3.1M |
| FY2025 | $-41.1M | $-41.2M | $66.0K | $4.7M |